Prions, proteinase K and infectivity

Prion

Volumn 6, Issue 5, 2012, Pages 430-432

  Sajnani, Gustavo ^a   Requena, Jesús R ^b  

^a National Paraplegia Hospital   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Infectivity; Prion; Resistant PrPSc; Sensitive PrPSc; Structure

Indexed keywords

AMYLOID; GUANIDINE; PRION PROTEIN; PROTEINASE K;

CREUTZFELDT JAKOB DISEASE; CYTOTOXICITY; DISEASE RESISTANCE; HUMAN; IN VIVO STUDY; NONHUMAN; PRION; PRION DISEASE; PROTEIN DENATURATION; REVIEW; VIRUS INFECTION;

ANIMALS; ENDOPEPTIDASE K; HUMANS; PROTEIN CONFORMATION; PROTEIN DENATURATION; PRPSC PROTEINS;

EID: 84869786006     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.22309     Document Type: Review

References (21)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44; PMID:6801762; http://dx.doi.org/10.1126/science. 6801762.
2. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540-2; PMID:21350487; http://dx.doi.org/10.1038/nature09768.
3. Hill AF, Collinge J. Subclinical prion infection. Trends Microbiol 2003; 11:578-84; PMID:14659690; http://dx.doi.org/10.1016/j.tim.2003.10.007.
4. Robinson M, Cheevers WP, Burger D, Gorham JRJ. Infect Dis 1990; 161:783-6; http://dx.doi.org/10.1093/infdis/161.4.783.
5. Gabizon R, McKinley MP, Prusiner SB. Properties of scrapie prion proteins in liposomes and amyloid rods. Ciba Found Symp 1988; 135:182-96; PMID:2900719.
6. Wille H, Zhang GF, Baldwin MA, Cohen FE, Prusiner SB. Separation of scrapie prion infectivity from PrP amyloid polymers. J Mol Biol 1996; 259:608-21; PMID:8683568; http://dx.doi.org/10.1006/jmbi.1996.0343.
7. Prusiner SB, McKinley MP, Groth DF, Bowman KA, Mock NI, Cochran SP, et al. Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci U S A 1981; 78:6675-9; PMID:6273882; http://dx.doi.org/10.1073/pnas.78.11.6675.
8. Wang JJ, Borwornpinyo R, Odetallah N, Shih JCH. Enzymatic degradation of a prion-like protein, Sup35NM-His6. Enzyme Microb Technol 2005; 36:758-65; http://dx.doi.org/10.1016/j.enzmictec.2004.12.023.
9. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157-65; PMID:9771749; http://dx.doi.org/10.1038/2654.
10. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, et al. Diagnosis of human prion disease. Proc Natl Acad Sci U S A 2005; 102:3501-6; PMID:15741275; http://dx.doi.org/10.1073/pnas.0409651102.
11. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005; 437:257-61; PMID:16148934; http://dx.doi.org/10.1038/nature03989.
12. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, et al. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008; 416:297-305; PMID:18684106; http://dx.doi.org/10.1042/BJ20081235.
13. Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, et al. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002; 41:12868-75; PMID:12379130; http://dx.doi.org/10.1021/ bi025958g.
14. Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, Soto C, et al. Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 2006; 45:15710-7; PMID:17176093; http://dx.doi.org/10.1021/ bi0615442.
15. Klingeborn M, Race B, Meade-White KD, Chesebro B. Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions. Proc Natl Acad Sci U S A 2011; 108:E1244-53; PMID:22065744; http://dx.doi.org/10.1073/pnas.1111255108.
16. Sajnani G, Silva CJ, Ramos A, Pastrana MA, Onisko BC, Erickson ML, et al. PK-sensitive PrPSc is infectious and shares basic structural features with PK-resistant PrPSc. PLoS Pathog 2012; 3:e1002547; http://dx.doi.org/10.1371/ journal.ppat.1002547.
17. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le Dur A, et al. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog 2010; 6:e1000859; PMID:20419156; http://dx.doi.org/10.1371/journal.ppat.1000859.
18. Ladiwala AR, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, Dordick JS, et al. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J Biol Chem 2010; 285:24228-37; PMID:20511235; http://dx.doi.org/10.1074/jbc.M110.133108.
19. Stathopulos PB, Scholz GA, Hwang YM, Rumfeldt JA, Lepock JR, Meiering EM. Sonication of proteins causes formation of aggregates that resemble amyloid. Protein Sci 2004; 13:3017-27; PMID:15459333; http://dx.doi.org/10.1110/ps. 04831804.
20. Kuroda Y, Maeda Y, Sawa S, Shibata K, Miyamoto K, Nakagawa T. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy. J Pept Sci 2003; 9:212-20; PMID:12725242; http://dx.doi.org/10. 1002/psc.447.
21. Colby DW, Giles K, Legname G, Wille H, Baskakov IV, DeArmond SJ, et al. Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A 2009; 106:20417-22; PMID:19915150; http://dx.doi.org/10.1073/pnas. 0910350106.